483
Takashi KamezawaFDA 483 - Takashi Kamezawa - December 05, 2025
Record Details
An FDA inspection of Takashi Kamezawa, a clinical investigator in Kasugai, Aichi, Japan, revealed significant deviations from an investigational plan. The firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan, specifically by enrolling subjects who were using prohibited concomitant medications. This non-compliance raises concerns about subject safety and data integrity within the clinical study.
View Company Profile
ID · 8f1aae0a-a6a5-4fd8-a5d5-be3802fd648b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.